NCT02482961View on ClinicalTrials.gov

Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

January 10, 2018

Study Completion Date

April 4, 2018

Conditions
Acinetobacter Infections
Interventions
DRUG

colistimethate sodium

At least once a week, all patients with carbapenem-resistant Acinetobacter baumannii infection were screened from the database at the clinical microbiology laboratory

Trial Locations (1)

411-773

Dongguk University Ilsan Hospital, Goyang

All Listed Sponsors
lead

DongGuk University

OTHER

NCT02482961 - Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection | Biotech Hunter | Biotech Hunter